Displaying items by tag: department of medicine
Cancer therapy puts patients at even greater risk of damage from the sun and heat.
New drug may slow the progression of chronic kidney disease in type 2 diabetics, increase kidney function and stave off dialysis.
With the acquisition, UAB takes a significant step toward making sophisticated cell therapy a part of patient care.
The risk factors for stroke in the South also may be responsible for cognitive decline.
By mapping a patient’s genome, and their tumor’s, with whole-genome sequencing, physicians can use more targeted therapies.
Tigatuzumab, developed at UAB with Daiichi-Sankyo, targets aggressive, hard-to-treat tumors that make up 25 percent of all breast cancers
Sleep deprivation, stress and a confused circadian clock can be a lethal combination
